Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.57 |
| ▸ | CTSL | P07711 | 3/20 | 0.53 |
| ▸ | CTSS | P25774 | 3/20 | 0.53 |
| ▸ | CTSK | P43235 | 3/20 | 0.53 |
| ▸ | CTSH | P09668 | 1/20 | 0.53 |
| ▸ | TACR1 | P25103 | 1/20 | 0.52 |
| ▸ | F2 | P00734 | 4/20 | 0.52 |
| ▸ | DPP3 | Q9NY33 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.50 |
| ▸ | CXCL8 | P10145 | 6/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29381047 | 0.96 | C5AR1 (0.62) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL30355006 | 0.94 | C5AR1 (0.64) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL30904766 | 0.94 | C5AR1 (0.65) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29389916 | 0.91 | C5AR1 (0.68) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29387436 | 0.91 | C5AR1 (0.68) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29756048 | 0.91 | C5AR1 (0.63) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29655661 | 0.91 | C5AR1 (0.63) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29794073 | 0.90 | C5AR1 (0.68) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL29655807 | 0.90 | C5AR1 (0.68) | C5AR1CTSLCTSSCTSKCTSH | |
| SCHEMBL30617830 | 0.89 | C5AR1 (0.61) | C5AR1CTSLCTSSCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4150057-A2 | PROCESS FOR PRODUCING DONOR-BATCHED CELLS EXPRESSING A RECOMBINANT RECEPTOR | Juno Therapeutics, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |